ImmuCell Corporation (ICCC) Financials
ICCC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 44.1 million | 15.0 million |
| Dec. 31, 2025 | 42.5 million | 15.5 million |
| Sept. 30, 2025 | 45.7 million | 15.9 million |
| June 30, 2025 | 46.7 million | 16.9 million |
ICCC Free Cash Flow and Stock based compensation
No data available :(
ICCC Net Income
No data available :(
ICCC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 6.8 million | 7.1 million | 4.0 million |
| Dec. 31, 2025 | 3.8 million | 7.5 million | 4.1 million |
| Sept. 30, 2025 | 3.9 million | 7.9 million | 4.0 million |
| June 30, 2025 | 6.0 million | 8.3 million | 4.5 million |
ICCC Shares Outstanding
ICCC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 177230 | 317688 | 1.2 million | 1.2 million |
| Dec. 31, 2025 | 172306 | 758864 | 2.2 million | 1.1 million |
| Sept. 30, 2025 | 593924 | 694311 | 1.6 million | 919291 |
| June 30, 2025 | 155159 | 831858 | 1.4 million | 696086 |
ICCC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 10.4 million | 5.7 million |
| Dec. 31, 2025 | 7.6 million | 4.7 million |
| Sept. 30, 2025 | 5.5 million | 3.1 million |
| June 30, 2025 | 6.4 million | 3.6 million |
ICCC Revenue by Segment
Graph available only for paid members. Upgrade to see it.
ICCC
Price: $9.49
52 week price:
Earnings Per Share: -0.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8519
Ebitda: 1.2 millionMarket Capitalization: 86.9 million